Iovance Biotherapeutics Inc
NASDAQ:IOVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
US |
|
M
|
Merck KGaA
OTC:MKKGY
|
DE |
|
Rheinmetall AG
OTC:RNMBY
|
DE |
|
U
|
UniCredit SpA
DUS:CRIN
|
IT |
|
Abbvie Inc
NYSE:ABBV
|
US |
|
United Microelectronics Corp
TWSE:2303
|
TW |
|
PAVmed Inc
NASDAQ:PAVM
|
US |
|
E
|
Eagle Materials Inc
SWB:E5M
|
US |
|
Triboo SpA
MIL:TB
|
IT |
|
D
|
Darling Ingredients Inc
SWB:43D
|
US |
|
Sailun Group Co Ltd
SSE:601058
|
CN |
|
Dream Impact Trust
TSX:MPCT.UN
|
CA |
|
REA Group Ltd
ASX:REA
|
AU |
|
T
|
TriSalus Life Sciences Inc
NASDAQ:TLSI
|
US |
|
A
|
American Eagle Outfitters Inc
F:AFG
|
US |
|
Kinder Morgan Inc
NYSE:KMI
|
US |
Multiples-Based Value
The Multiples-Based Value for
Iovance Biotherapeutics Inc (IOVA) under the Base Case is hidden
USD.
Compared with the current market price of 4.095 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.